I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Muls, V
37
results:
Search for persons
X
Format
Online (37)
Mediatypes
Articles (Online) (25)
OpenAccess-fulltext (12)
Sorted by: Relevance
Sorted by: Year
?
1
P842 SARS-CoV-2 antibody titers analysis in immune mediated..:
Delaleeuwe, I
;
Aoun, J
;
Hoyois, A
...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i968-i969 , 2023
Link:
https://doi.org/10.1093/..
?
2
OP28 A randomized placebo controlled clinical trial with 5-..:
Truyens, M
;
Lobaton, T
;
Peeters, A
...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i029-i032 , 2022
Link:
https://doi.org/10.1093/..
?
3
P527 Investigating fatigue in vedolizumab-treated patients ..:
Louis, E
;
Muls, V
;
Bossuyt, P
...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S503-S503 , 2021
Link:
https://doi.org/10.1093/..
?
4
P600 Vedolizumab dose optimisation: Findings from a Belgian..:
Louis, E
;
Muls, V
;
Bossuyt, P
...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S501-S502 , 2020
Link:
https://doi.org/10.1093/..
?
5
P603 Persistence of vedolizumab maintenance therapy: Findin..:
Louis, E
;
Muls, V
;
Bossuyt, P
...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S503-S504 , 2020
Link:
https://doi.org/10.1093/..
?
6
P131 Effectiveness and safety of vedolizumab maintenance th..:
Louis, E
;
Muls, V
;
Bossuyt, P
...
Journal of Crohn's and Colitis. 13 (2019) Supplement_1 - p. S153-S154 , 2019
Link:
https://doi.org/10.1093/..
?
7
P723 Effectiveness and persistence of vedolizumab in patien..:
Reenaers, C
;
Cremer, A
;
Dewit, O
...
Journal of Crohn's and Colitis. 12 (2018) supplement_1 - p. S476-S477 , 2018
Link:
https://doi.org/10.1093/..
?
8
Transanal endolaparoscopic circumferential mucosectomy for ..:
Dapri, G.
;
Van Gossum, M.
;
Muls, V.
.
Colorectal Disease. 19 (2017) 2 - p. 210-211 , 2017
Link:
https://doi.org/10.1111/..
?
9
P550 Diagnosing and treating pediatric Crohn's disease pati..:
De Greef, E.
;
Maus, B.
;
Hoffman, I.
...
Journal of Crohn's and Colitis. 7 (2013) - p. S231 , 2013
Link:
https://doi.org/10.1016/..
?
10
Profile of pediatric Crohn's disease in Belgium:
De Greef, E.
;
Mahachie John, J.M.
;
Hoffman, I.
...
Journal of Crohn's and Colitis. 7 (2013) 11 - p. e588-e598 , 2013
Link:
https://doi.org/10.1016/..
?
11
P320 Factors determining therapeutic strategy at diagnosis ..:
De Greef, E.
;
Mahachie, J.
;
Hofman, I.
...
Journal of Crohn's and Colitis. 6 (2012) - p. S137 , 2012
Link:
https://doi.org/10.1016/..
?
12
Limitations of extensive TPMT genotyping in the management ..:
Dewit, O.
;
Moreels, T.
;
Baert, F.
...
Clinical Biochemistry. 44 (2011) 13 - p. 1062-1066 , 2011
Link:
https://doi.org/10.1016/..
?
13
Upper gastrointestinal endoscopic findings in the era of hi..:
Nkuize, M
;
De Wit, S
;
Muls, V
..
HIV Medicine. 11 (2010) 6 - p. 412-417 , 2010
Link:
https://doi.org/10.1111/..
?
14
Dyspeptic symptoms in the general population: a factor and ..:
piessevaux, h.
;
de winter, b.
;
louis, e.
...
Neurogastroenterology & Motility. 21 (2009) 4 - p. 378-388 , 2009
Link:
https://doi.org/10.1111/..
?
15
2110 POSTER Active specific immunotherapy with NGcGM3/ VSSP..:
Macias, A.
;
Torres, A.
;
Montenegro, A.
...
European Journal of Cancer Supplements. 5 (2007) 4 - p. 217 , 2007
Link:
https://doi.org/10.1016/..
1-15